Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain.
Saved in:
| Title: | Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain. |
|---|---|
| Authors: | Moreno, Santiago1 (AUTHOR), Rivero, Antonio2 (AUTHOR), Ventayol, Pere3 (AUTHOR), Falcó, Vicenç4 (AUTHOR), Torralba, Miguel5 (AUTHOR), Schroeder, Melanie6 (AUTHOR), Neches, Victoria7 (AUTHOR) victoria.x.neches@gsk.com, Vallejo-Aparicio, Laura Amanda7 (AUTHOR), Mackenzie, Isaac8 (AUTHOR), Turner, Matthew8 (AUTHOR), Harrison, Cale8 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Aug2023, Vol. 12 Issue 8, p2039-2055. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
